Annual Non Current Assets
$490.00 K
-$243.00 K-33.15%
31 December 2023
Summary:
Galectin Therapeutics annual long term assets is currently $490.00 thousand, with the most recent change of -$243.00 thousand (-33.15%) on 31 December 2023. During the last 3 years, it has risen by +$355.00 thousand (+262.96%). GALT annual non current assets is now -33.15% below its all-time high of $733.00 thousand, reached on 31 December 2022.GALT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$306.00 K
-$62.00 K-16.85%
30 September 2024
Summary:
Galectin Therapeutics quarterly long term assets is currently $306.00 thousand, with the most recent change of -$62.00 thousand (-16.85%) on 30 September 2024. Over the past year, it has dropped by -$246.00 thousand (-44.57%). GALT quarterly non current assets is now -61.41% below its all-time high of $793.00 thousand, reached on 30 September 2022.GALT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.1% | -44.6% |
| 3 y3 years | +263.0% | +665.0% |
| 5 y5 years | +181.6% | +6.6% |
GALT Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -33.1% | +6900.0% | -61.4% | +4271.4% |
| 5 y | 5 years | -33.1% | +6900.0% | -61.4% | +4271.4% |
| alltime | all time | -33.1% | >+9999.0% | -61.4% |
Galectin Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $306.00 K(-16.8%) |
| June 2024 | - | $368.00 K(-14.4%) |
| Mar 2024 | - | $430.00 K(-12.2%) |
| Dec 2023 | $27.71 M(+34.8%) | $490.00 K(-11.2%) |
| Sept 2023 | - | $552.00 K(-10.0%) |
| June 2023 | - | $613.00 K(-8.9%) |
| Mar 2023 | - | $673.00 K(-8.2%) |
| Dec 2022 | $20.55 M(-50.9%) | $733.00 K(-7.6%) |
| Sept 2022 | - | $793.00 K(+685.1%) |
| June 2022 | - | $101.00 K(-6.5%) |
| Mar 2022 | - | $108.00 K(+1442.9%) |
| Dec 2021 | $41.82 M(+41.9%) | $7000.00(-82.5%) |
| Sept 2021 | - | $40.00 K(-43.7%) |
| June 2021 | - | $71.00 K(-31.1%) |
| Mar 2021 | - | $103.00 K(-23.7%) |
| Dec 2020 | $29.46 M(-38.9%) | $135.00 K(-18.7%) |
| Sept 2020 | - | $166.00 K(-15.7%) |
| June 2020 | - | $197.00 K(-13.2%) |
| Mar 2020 | - | $227.00 K(-12.0%) |
| Dec 2019 | $48.21 M(+445.8%) | $258.00 K(-10.1%) |
| Sept 2019 | - | $287.00 K(-9.5%) |
| June 2019 | - | $317.00 K(-8.6%) |
| Mar 2019 | - | $347.00 K(+99.4%) |
| Dec 2018 | $8.83 M(+131.3%) | $174.00 K(+102.3%) |
| Sept 2018 | - | $86.00 K(-50.0%) |
| June 2018 | - | $172.00 K(-33.3%) |
| Mar 2018 | - | $258.00 K(-24.6%) |
| Dec 2017 | $3.82 M(-75.8%) | $342.00 K(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $15.79 M(-40.2%) | $1000.00(-66.7%) |
| Sept 2016 | - | $3000.00(-40.0%) |
| June 2016 | - | $5000.00(-28.6%) |
| Mar 2016 | - | $7000.00(-12.5%) |
| Dec 2015 | $26.40 M(-11.0%) | $8000.00(-20.0%) |
| Sept 2015 | - | $10.00 K(-16.7%) |
| June 2015 | - | $12.00 K(-14.3%) |
| Mar 2015 | - | $14.00 K(-12.5%) |
| Dec 2014 | $29.66 M(+177.5%) | $16.00 K(-42.9%) |
| Sept 2014 | - | $28.00 K(-66.7%) |
| June 2014 | - | $84.00 K(-45.5%) |
| Mar 2014 | - | $154.00 K(+492.3%) |
| Dec 2013 | $10.69 M(+12.3%) | $26.00 K(-25.7%) |
| Sept 2013 | - | $35.00 K(-7.9%) |
| June 2013 | - | $38.00 K(-7.3%) |
| Mar 2013 | - | $41.00 K(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $9.52 M(+46.4%) | $44.00 K(-2.2%) |
| Sept 2012 | - | $45.00 K(-57.9%) |
| June 2012 | - | $107.00 K(-1.8%) |
| Mar 2012 | - | $109.00 K(-1.8%) |
| Dec 2011 | $6.50 M(+4.9%) | $111.00 K(+2.8%) |
| Sept 2011 | - | $108.00 K(+2.9%) |
| June 2011 | - | $105.00 K(+1.9%) |
| Mar 2011 | - | $103.00 K(-1.9%) |
| Dec 2010 | $6.20 M(+1937.8%) | $105.00 K(-13.2%) |
| Sept 2010 | - | $121.00 K(-2.4%) |
| June 2010 | - | $124.00 K(-3.1%) |
| Mar 2010 | - | $128.00 K(-3.0%) |
| Dec 2009 | $304.00 K(-20.0%) | $132.00 K(-55.1%) |
| Sept 2009 | - | $294.00 K(-3.0%) |
| June 2009 | - | $303.00 K(-3.2%) |
| Mar 2009 | - | $313.00 K(-3.4%) |
| Dec 2008 | $380.00 K(-72.6%) | $324.00 K(-4.1%) |
| Sept 2008 | - | $338.00 K(-7.4%) |
| June 2008 | - | $365.00 K(-3.2%) |
| Mar 2008 | - | $377.00 K(-4.1%) |
| Dec 2007 | $1.39 M(-76.6%) | $393.00 K(-15.5%) |
| Sept 2007 | - | $465.00 K(-3.1%) |
| June 2007 | - | $480.00 K(+8.8%) |
| Mar 2007 | - | $441.00 K(+3.3%) |
| Dec 2006 | $5.94 M(+26.5%) | $427.00 K(+10.9%) |
| Sept 2006 | - | $385.00 K(+20.7%) |
| June 2006 | - | $319.00 K(+19.9%) |
| Mar 2006 | - | $266.00 K(-1.1%) |
| Dec 2005 | $4.69 M(-56.6%) | $269.00 K(-24.2%) |
| Sept 2005 | - | $355.00 K(+4.1%) |
| June 2005 | - | $341.00 K(+11.8%) |
| Mar 2005 | - | $305.00 K(+6.6%) |
| Dec 2004 | $10.82 M(+40.6%) | $286.00 K(-6.5%) |
| Sept 2004 | - | $306.00 K(+3.7%) |
| June 2004 | - | $295.00 K(-4.9%) |
| Mar 2004 | - | $310.30 K(+1.4%) |
| Dec 2003 | $7.70 M(+286.0%) | $306.00 K(-3.7%) |
| Sept 2003 | - | $317.70 K(-1.6%) |
| June 2003 | - | $323.00 K(+1.8%) |
| Mar 2003 | - | $317.30 K(+9.7%) |
| Dec 2002 | $1.99 M(+26.9%) | $289.20 K(+7.2%) |
| Sept 2002 | - | $269.70 K(-3.2%) |
| June 2002 | - | $278.50 K(+19.0%) |
| Mar 2002 | - | $234.00 K(+20.2%) |
| Dec 2001 | $1.57 M | $194.60 K(-35.7%) |
| Sept 2001 | - | $302.50 K(+63.7%) |
| June 2001 | - | $184.80 K |
FAQ
- What is Galectin Therapeutics annual long term assets?
- What is the all time high annual non current assets for Galectin Therapeutics?
- What is Galectin Therapeutics annual non current assets year-on-year change?
- What is Galectin Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly non current assets year-on-year change?
What is Galectin Therapeutics annual long term assets?
The current annual non current assets of GALT is $490.00 K
What is the all time high annual non current assets for Galectin Therapeutics?
Galectin Therapeutics all-time high annual long term assets is $733.00 K
What is Galectin Therapeutics annual non current assets year-on-year change?
Over the past year, GALT annual long term assets has changed by -$243.00 K (-33.15%)
What is Galectin Therapeutics quarterly long term assets?
The current quarterly non current assets of GALT is $306.00 K
What is the all time high quarterly non current assets for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly long term assets is $793.00 K
What is Galectin Therapeutics quarterly non current assets year-on-year change?
Over the past year, GALT quarterly long term assets has changed by -$246.00 K (-44.57%)